Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04690374 · ClinicalTrials.gov registry record
Registry to Collect Health Information About Desmoplastic Small Round Cell Tumor
A clinical trial of Desmoplastic Small Round Cell Tumor, sponsored by Memorial Sloan Kettering Cancer Center.
- Recruiting
- Registry status
- 250
- Enrollment target
- 1
- Study location
NCT04690374 is a study of Desmoplastic Small Round Cell Tumor that is actively recruiting participants, run by Memorial Sloan Kettering Cancer Center. The registered enrollment target is 250 participants, above the 39-participant average among 7 other Desmoplastic Small Round Cell Tumor trials with a reported enrollment target (541% higher). The trial reports 1 study location across 1 state.
The verdict
NCT04690374, a study of Desmoplastic Small Round Cell Tumor, is actively recruiting participants, sponsored by Memorial Sloan Kettering Cancer Center.
- RECRUITING
- Registry status
- 250 participants
- Enrollment target
- 1
- Study location
Study Summary
This study is a patient registry of people with Desmoplastic Small Round Cell Tumor (DSRCT). A patient registry is a collection of health information about a group of people, and it is usually focused on a specific diagnosis or disease. The purpose of this registry is to create a database- a collection of information-or better understanding DSRCT. Researchers will use the information from this database to learn more about DSRCT and for current and future research on DSRCT.
Conditions Studied
Study Locations (1)
New York
- Memorial Sloan Kettering Cancer Center (All Protocol Activities) - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 250 participants |
| Start Date | 2020-12-22 |
| Est. Completion | 2027-12 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04690374
The ClinicalTrials.gov registry entry for NCT04690374 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 250 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 39-participant average among 7 other Desmoplastic Small Round Cell Tumor trials with a reported enrollment target (541% higher). The listed sponsor is Memorial Sloan Kettering Cancer Center, which has 1,884 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Desmoplastic Small Round Cell Tumor appearing as the primary indexed condition, and to 0 interventions.
NCT04690374 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.
Frequently Asked Questions
What is clinical trial NCT04690374 about?
NCT04690374 is a clinical study titled "Registry to Collect Health Information About Desmoplastic Small Round Cell Tumor". This study is a patient registry of people with Desmoplastic Small Round Cell Tumor (DSRCT). A patient registry is a collection of health information about a group of people, and it is usually focused on a specific diagnosis or disease. The purpose of this registry is to create a database- a collec...
What is the current status of trial NCT04690374?
This trial is currently recruiting. The enrollment target is 250 participants. The study started on 2020-12-22. Estimated completion is 2027-12.
What conditions does trial NCT04690374 study?
This clinical trial studies the following conditions: Desmoplastic Small Round Cell Tumor.
Who is sponsoring clinical trial NCT04690374?
This trial is sponsored by Memorial Sloan Kettering Cancer Center, which has 1,884 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04690374 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Desmoplastic Small Round Cell Tumor
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
B7-H3-Specific Chimeric Antigen Receptor Autologous T-Cell Therapy for Pediatric Patients With Solid Tumors (3CAR)
RECRUITING · Phase 1
-
Phase 1/2 Trial to Evaluate the Safety and Efficacy of PEEL-224 in Combination With Vincristine and Temozolomide in Adolescents and Young Adults With Relapsed or Refractory Sarcomas
RECRUITING · Phase 1
-
Alpha/Beta T and B Cell Depletion With Zoledronic Acid for Solid Tumors
RECRUITING · Phase 1
-
Lurbinectedin in FET-Fused Tumors
RECRUITING · Phase 1
-
Therapeutic Trial for Patients With Ewing Sarcoma Family of Tumor and Desmoplastic Small Round Cell Tumors
ACTIVE NOT RECRUITING · Phase 2
-
CAMPFIRE: A Study of Ramucirumab (LY3009806) in Children and Young Adults With Desmoplastic Small Round Cell Tumor
ACTIVE NOT RECRUITING · Phase 1
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.